# StaveMD reviews (2026): GLP-1 telehealth sellers | This GLP StaveMD advertises flat-dose treatment and a refund if no prescription is issued. Its introductory period and ongoing plan should be read separately. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/stavemd Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated October 2026 A compounded GLP-1 platform with a clear distinction between free eligibility checking and paid clinical review. # Does StaveMD sell a GLP-1? StaveMD advertises flat-dose treatment and a refund if no prescription is issued. Its introductory period and ongoing plan should be read separately. ## The verdict The payment sequence and prescription-declined refund are useful disclosures. Confirm the clinician’s follow-up plan and exact formulation; a platform’s support claim is not proof of round-the-clock clinical care. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Dose pricing Flat across doses Prescription Required Compounded Yes — not FDA-approved StaveMD is a telehealth platform connecting adults with independent licensed providers and a US-licensed pharmacy. It expressly says it does not practice medicine or dispense medication. 1. ## Who writes the prescription, and what do they see? The initial eligibility check is not a medical consultation and does not guarantee a prescription. A licensed provider reviews the request after the paid checkout stage. The site advertises provider review and ongoing support. Ask who answers medication questions, how scheduled follow-up works and what response times apply to clinical messages. 2. ## What happens when the dose goes up? The semaglutide page says the price does not increase with dose. Treatment changes still depend on the clinician’s assessment, not the price structure or a desire to use a larger supply. 3. ## What the price includes The first semaglutide offer is described as a four-week introductory period, followed by a stated monthly renewal. Confirm the billing interval and renewal amount rather than treating those labels as identical. 4. ## What it claims, and what it cites Compounded semaglutide and tirzepatide are named. The semaglutide page explicitly distinguishes its compound from Ozempic and Wegovy. Compounded medicines are not FDA-approved substitutes for branded products. ## Where it holds up, and where it does not - Strength: Separates eligibility screening from prescribing - Strength: Explicitly distinguishes compounds from branded medicines - Limitation: Clinical response times need confirmation - Limitation: First-period and renewal intervals need careful reading ## What the evidence says about this kind of treatment The assessment above is about StaveMD. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for Adults who want the approval and payment sequence explained before starting intake. Wrong for Anyone who assumes a free eligibility check is clinical approval or that a promotional first period is the continuing price. ## The evidence behind what StaveMD prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How StaveMD compares | Seller | Who it suits | Go | | --- | --- | --- | | SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | | | ShedRx | Readers willing to telephone a seller and ask which published fee is the real one | | | RxSpan MD | Buyers who want the standing rate, the pharmacy and the prescriber named before signing up | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [Enara Health](https://thisglp.com/reviews/enara-health) [Enhanced](https://thisglp.com/reviews/enhanced) [EverFit Medical](https://thisglp.com/reviews/everfit-medical) [Evergreen Telehealth](https://thisglp.com/reviews/evergreen-telehealth) [Evernow](https://thisglp.com/reviews/evernow) [Evolve Telemed](https://thisglp.com/reviews/evolve-telemed) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked Does the free check establish eligibility for a prescription? No. It is an initial screen. A licensed provider must still review the request and decide whether treatment is appropriate. Is compounded semaglutide the same as Wegovy? No. The product page expressly distinguishes its compound from branded semaglutide medicines. ## Sources for this review Provider information checked October 26, 2026. Terms can change. - [Official service overview](https://stavemd.com/) - [Official program and terms](https://stavemd.com/terms) - [Official program and terms](https://stavemd.com/semaglutide) Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).